Reducing HIV transmission among drug injectors lowers AIDS mortality in heterosexuals
The study examined longitudinal data from across the US, incorporating epidemic history, HIV prevalence rate, history of prevention programming, and socioeconomic contexts
21-Feb-2014- Although community network studies show that sexual relationships occur between members of
"risk groups" -- men who have sex with other men (MSM), people who inject drugs (PWID), non-injection drug users (NIDU) -- and
heterosexuals, researchers at New York University's Center for Drug Use and HIV Research (CDUHR) note that little research
has been done to help explain how HIV epidemics and programs in one population affect others and how to reduce the risks of transmission.
A recent study conducted by researchers from CDUHR, led by Samuel R. Friedman, Director of both CDUHR's Interdisciplinary
Theoretical Synthesis Core, and the Institute for Infectious Disease Research at NDRI, sheds light on the pathways connecting HIV
epidemics in different populations.
It shows that programs for people who use drugs-like syringe exchange, HIV counseling and testing, and drug abuse
treatment-are associated with subsequent lower rates of AIDS incidence and death among heterosexuals.
"Since existing theory and research have relatively little to say about the cross-population processes being studied, we
used exploratory analytic technique to study these relationships," explains Dr. Friedman.
The objective of the study, "Do metropolitan HIV epidemic histories and programs for people who inject drugs and men who
have sex with men predict AIDS incidence and mortality among heterosexuals?" was to better understand how epidemics among MSMs and
PWIDs correlate with later epidemics and mortality within heterosexuals; how prevention programs targeting specific groups affect
future epidemics among other populations; and whether the size of MSM and PWID populations are associated with the later
epidemics and mortalities among heterosexuals. The study was published in the Annals of Epidemiology.
The study looked at data from 96 large US metropolitan statistical areas (MSAs) from 1992 - 2008. "We have only limited
ability to study the mechanisms by which our independent variables come to be associated with outcomes," explains Dr. Friedman.
"Research into whether interventions in one key population affect HIV epidemics in other key populations is of high policy
relevance and should be a priority."
Although the study highlights the necessity of future studies, it found that HIV counseling and testing in PWIDs was
associated with lower AIDS incidence in heterosexuals, while counseling and testing in MSMs were not; and that availability of
syringe exchange programs and drug abuse treatment programs were associated with lower AIDS death rates among heterosexuals.
The study also highlights a link between racial/ethnic residential segregation and rates of AIDS incidence and mortality
among heterosexuals and points to evidence pairing social causations like income inequality with mortality.
"Our findings are descriptive of the relationships of the measured variables in these large metropolitan areas," said Dr. Friedman.
"They do not, however, imply that these findings can necessarily be extended to smaller MSAs, non-metropolitan localities, other
time periods or other countries, for that further research is clearly needed."
Acknowledgements: This work was supported by National Institute of Drug Abuse grants # R01 DA013336 (Community
Vulnerability and Responses to Drug-User-Related HIV/AIDS), R01 DA 003574 (Risk Factors for AIDS among Intravenous Drug Users),
and 5T32 DA007233 (Behavioral Sciences Training in Drug Abuse Research program sponsored by Public Health Solutions and
National Development and Research Institutes). The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
The research team members include: S.R Friedman, B.S West, B Tempalski, C.M Morton, C.M Cleland, D.C.D Jarlais, H.I Hall,
H.L.F Cooper. Affiliations: Institute of Infectious Disease Research, National Development and Research Institutes Inc. (SRF,BSW,BT,CMM),
New York, NY USA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health (SRF), Baltimore, MD, USA; NYU College of
Nursing (CMC), New York, NY USA; Beth Israel Medical Center (DCDJ), New York, NY USA; Division of HIV/AIDS Prevention, National Center
for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention (HIH), Atlanta, GA USA; Behavioral
Sciences and Health Education, Rollins School of Public Health at Emory University (HLFC), Atlanta, GA USA.
CDUHR, funded by the National Institute on Drug Abuse, is the first center for the socio-behavioral study of substance use and HIV in
the United States. The Center is dedicated to increasing the understanding of the substance use-HIV/AIDS epidemic, particularly among
individuals in high-risk contexts. The Center's theme is "Discovery to Implementation & Back: Research Translation for the
HIV/Substance Use Epidemic." The Center facilitates the development of timely new research efforts, enhances implementation
of funded projects and disseminates information to researchers, service providers and policy makers.
About New York University College of Nursing
NYU College of Nursing is a global leader in nursing education, research, and practice. It offers a Bachelor of Science in Nursing, a
Master of Arts and Post-Master's Certificate Programs, a Doctor of Philosophy in Research Theory and Development, and a Doctor of
Nursing Practice degree. For more information, visit http://www.nyu.edu/nursing .
New York University
For more HIV and AIDS News visit...
Positively Positive - Living with HIV/AIDS: